Subscribe and receive the latest insights on the health and nutrition industry.
Join 37,000+ members. Yes, it's completely free.
November 7, 2017
InstantGMP™ Electronic Batch Record software now features an inventive new feature, a Document Management System (DMS).
Enjoy the ease of precision through the DMS’s integration with Master and Batch Production Records as the feature automatically checks document versioning to alert Quality Managers of changes. Update controlled production documents directly from the Master Record with the click of the mouse. This check ensures that all documentation for production always stays up to date to prevent disruptions during batch production. This new feature is especially beneficial for Pharmaceutical, Biotech, and Cannabis manufacturers or any quality-minded organization.
Additionally, the process to add and approve documents is a breeze. Once uploaded, the system notifies approvers through system-generated email alerts. Documents are interactive and can be updated or modified before approval, with a complete document history recording the changes. Users sign with their 21 CFR Part 11 compliant digital signatures once a document is ready to be approved.
The Document Management System is available as a feature of the flagship InstantGMP™ software, or as a stand-alone software for those not quite prepared for Electronic Batch Records, but want to take advantage of document management.
To see the new Document Management System in action, be sure to watch a brief video. For a more comprehensive look at the DMS, please submit a request for a live demonstration.
About InstantGMP, Inc.
InstantGMP™ Electronic Batch Software is the brain-child of former Head of Worldwide Research & Development for SmithKline Beecham, Dr. Richard Soltero. Originally devised as a Good Manufacturing Practice (GMP) compliance software, InstantGMP™ has evolved into a Manufacturing Execution System (MES) with a difference. Invest in success with InstantGMP™ software from InstantGMP, Inc.!
You May Also Like
Tianeptine sales spur another FDA warning, action by state lawmakersFeb 20, 2024
Formulating the future: The industry may not be ready for AI in product development, and AI might not be ready for the industry, eitherFeb 20, 2024
Beyond the primary outcome: How exploratory analysis can deliver unexpected new insightsFeb 19, 2024
Survey shows dietitians concerned about TikTok misinformationFeb 16, 2024